• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Client Solutions
    • Digital Transformation
    • Energy Transition
    • Supply Chains
    • Sustainability and ESG
    • Workforce Redesign
  • Sectors
    • Consumer Goods & Retail
    • Energy, Mining & Infrastructure
    • Financial Institutions
    • Healthcare & Life Sciences
    • Industrials, Manufacturing & Transportation
    • Technology
  • Learning Resources
    • Podcasts
    • Video Chats
    • Webinars
  • Area of Law
    • Antitrust & Competition
    • Artificial Intelligence
    • Banking & Finance
    • Capital Markets
    • Cybersecurity & Data Privacy
    • Data & Technology
    • Dispute Resolution
    • Employment & Compensation
    • Environment & Climate Change
    • Financial Services Regulatory
    • Inclusion, Diversity & Equity
    • Intellectual Property
    • International Commercial & Trade
    • Investigations, Compliance & Ethics
    • Mergers & Acquisitions
    • Pensions
    • Private Equity
    • Projects
    • Real Estate
    • Restructuring & Insolvency
    • Tax
  • Location
    • International

    • International
    • Asia Pacific

    • Australia
    • China
    • Hong Kong
    • Indonesia
    • Japan
    • Malaysia
    • South Korea (Korea, Republic of)
    • Singapore
    • Taipei
    • Thailand
    • Philippines
    • Vietnam
    • EMEA

    • Austria
    • Bahrain
    • Belgium
    • Czech Republic
    • Egypt
    • EU
    • France
    • Germany
    • Hungary
    • Italy
    • Kazakhstan
    • Luxembourg
    • Morocco
    • Netherlands
    • Poland
    • Portugal
    • Qatar
    • Russian Federation
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Türkiye
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • North America

    • Canada
    • United States
    • Latin America

    • Argentina
    • Brazil
    • Colombia
    • Chile
    • Mexico
    • Peru
    • Venezuela
Baker McKenzie InsightPlus Home
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Client Solutions
    • Digital Transformation
    • Energy Transition
    • Supply Chains
    • Sustainability and ESG
    • Workforce Redesign
  • Sectors
    • Consumer Goods & Retail
    • Energy, Mining & Infrastructure
    • Financial Institutions
    • Healthcare & Life Sciences
    • Industrials, Manufacturing & Transportation
    • Technology
  • Learning Resources
    • Podcasts
    • Video Chats
    • Webinars
  • Area of Law
    • Antitrust & Competition
    • Artificial Intelligence
    • Banking & Finance
    • Capital Markets
    • Cybersecurity & Data Privacy
    • Data & Technology
    • Dispute Resolution
    • Employment & Compensation
    • Environment & Climate Change
    • Financial Services Regulatory
    • Inclusion, Diversity & Equity
    • Intellectual Property
    • International Commercial & Trade
    • Investigations, Compliance & Ethics
    • Mergers & Acquisitions
    • Pensions
    • Private Equity
    • Projects
    • Real Estate
    • Restructuring & Insolvency
    • Tax
  • Location
    • International

    • International
    • Asia Pacific

    • Australia
    • China
    • Hong Kong
    • Indonesia
    • Japan
    • Malaysia
    • South Korea (Korea, Republic of)
    • Singapore
    • Taipei
    • Thailand
    • Philippines
    • Vietnam
    • EMEA

    • Austria
    • Bahrain
    • Belgium
    • Czech Republic
    • Egypt
    • EU
    • France
    • Germany
    • Hungary
    • Italy
    • Kazakhstan
    • Luxembourg
    • Morocco
    • Netherlands
    • Poland
    • Portugal
    • Qatar
    • Russian Federation
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Türkiye
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • North America

    • Canada
    • United States
    • Latin America

    • Argentina
    • Brazil
    • Colombia
    • Chile
    • Mexico
    • Peru
    • Venezuela
  1. Healthcare & Life Sciences
  2. Singapore: Due process in an internal inquiry – Appellate Division clarifies scope of employers’ obligations

Singapore: Due process in an internal inquiry – Appellate Division clarifies scope of employers’ obligations

03 Sept 2025    5 minute read
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Facebook
    • Google plus
    • Get link
    • Get QR Code
    • Download
    • Print
Sectors Healthcare & Life Sciences
Employment Law Termination Employee Misconduct Due Process Disciplinary Inquiry Healthcare & Life Sciences (HLS) DR Featured Content

In brief

In Tan Tung Wee Eddie v. Singapore Health Services Pte Ltd [2025] SGHC(A) 12, the Appellate Division of the High Court of Singapore (“AD”) dismissed an appeal by a consultant neurosurgeon who claimed that he had been wrongfully dismissed because he was not given a chance to respond to additional data audit findings that had been considered by a disciplinary council convened by his employer, in deciding to summarily dismiss him for misconduct. These data audit findings were considered by the disciplinary council after the inquiry into allegations of his misconduct had concluded.

The AD found that the employer had fulfilled its contractual obligation to the employee to provide due process by convening a Committee of Inquiry (COI) to investigate the misconduct allegations against the employee. The fact that the disciplinary council subsequently considered additional data audit findings when reaching its ultimate decision to summarily dismiss the employee did not trigger a separate obligation to hear the employee’s response to the data audit findings which had not been the subject of the inquiry.


Contents

Key takeaways

  • The decision provides helpful guidance to employers and employees on their rights and obligations during an inquiry into allegations of misconduct. Specifically, the scope and extent of the parties’ due process rights and obligations, in the context of employee misconduct, are circumscribed by the wording of the employment contract.
  • In an internal inquiry, further evidence of wrongdoing is oftentimes still being uncovered after the initial investigations are complete and before a disciplinary decision is taken.  Although each case will turn on the specific facts and wording of the employment contract, this decision suggests that employers are not generally required to convene a new inquiry into, or provide employees with a separate opportunity to respond to, each and every additional finding falling outside the scope of the original disciplinary inquiry.
  • Once the procedure of the disciplinary proceedings set out in the employment contract is followed, further procedural rights do not arise unless expressly provided for in the employment contract. Employers should carefully review and be aware of their obligations under their employment contracts and relevant employee-facing policies.
  • On the facts of this case, the Court found that the misconduct allegations were established based on the findings of the initial investigation, during which the employee was given an opportunity to respond to the allegations. The additional findings were thus not strictly necessary to establish the employee’s misconduct. However, if the additional findings had been necessary to establish the employee’s misconduct, the position remains open as to whether the employer would have had an obligation to give the employee an opportunity to respond to those additional findings.  

In depth

Factual background

  • Tan Tung Wee Eddie (“Dr. Tan”) was employed by Singapore Health Services Pte Ltd (“SingHealth”) as a Consultant Neurosurgeon at the National Neuroscience Institute (NNI). The terms of Dr. Tan’s employment included a ‘COI Policy’ and a ‘Discipline Policy’.
  • In 2021, a whistleblower reported that Dr. Tan had been intentionally targeting other doctors by accessing the medical records of certain patients, in breach of patient confidentiality, and using those records to find fault with the other doctors (“Misconduct Allegations”). A COI was accordingly convened to investigate the Misconduct Allegations.
  • •The COI uncovered that Dr. Tan had improperly accessed the records of 42 patients. The COI also interviewed Dr. Tan and invited him to provide a written response, in the course of which Dr. Tan admitted to accessing patient records in breach of patient confidentiality. Nonetheless, the COI recommended that Dr. Tan be issued a formal warning only. Pursuant to the COI Policy and Discipline Policy, a SingHealth Disciplinary Council (SDC) was convened, with the power to review the COI’s recommendation and decide on the punishment to be meted out. 
  • The SDC ultimately decided to dismiss Dr. Tan. However, in coming to its decision, the SDC considered the COI report as well as an NNI Data Audit which was completed after the COI report was delivered. The NNI Data Audit set out details of other instances of patient confidentiality breaches by Dr. Tan which were not considered by the COI.

Grounds of appeal

  • Dr. Tan’s sole ground of appeal was that SingHealth had been contractually required to provide him with an opportunity to respond to the NNI Data Audit before dismissing him.
  • Dr. Tan’s argument was based on a provision in the COI Policy requiring that an employee under investigation “shall be granted due process and an opportunity to explain himself in disciplinary proceedings”.

Legal principles

  • Where a contractually appointed body decides on a party’s rights under contract, there is no general duty for a party exercising this right to act fairly or observe natural justice.
  • As such, the scope and extent of any procedural rights or obligations under such a decision-making process, such as fairness, natural justice, or due process, is determined by the specific contractual terms governing that process.

AD’s decision

  • Dismissing the appeal, the AD held that the contractual terms governing the disciplinary proceedings did not oblige SingHealth to give Dr. Tan an opportunity to respond to the NNI Data Audit.
  • The AD found that under the COI Policy and Discipline Policy, SingHealth was obliged to convene a COI to investigate the facts of the Misconduct Allegations, report its factual findings, and recommend appropriate disciplinary action. The SDC was then responsible for reviewing the recommendation and deciding the appropriate action, not reviewing the fact-finding exercise.
  • Accordingly, the obligation to grant Dr. Tan ‘due process and an opportunity to explain himself’ was limited to the ambit of the disciplinary proceedings against Dr. Tan, which was in turn circumscribed by the particular Misconduct Allegations investigated by the COI. 
  • Therefore, once the COI had granted Dr. Tan the opportunity to respond to the Misconduct Allegations that the COI had been investigating, the obligation of due process under the COI Policy had been discharged. The mere fact that the NNI Data Audit   raised other instances of unauthorised data access did not oblige SingHealth to re-convene a COI to investigate those other instances. 
  • As such, SingHealth could not have been obliged to give Dr. Tan an opportunity to respond to the NNI Data Audit because the NNI Data Audit did not fall within the ambit of the disciplinary proceedings against him.

* * * * *

LOGO_Wong&Leow_Singapore

© 2025 Baker & McKenzie. Wong & Leow. All rights reserved. Baker & McKenzie. Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information
Celeste Ang
Principal
Singapore
Read my Bio
celeste.ang@bakermckenzie.com
Pradeep Nair
Local Principal
Singapore
Read my Bio
pradeep.nair@bakermckenzie.com

Copyright © 2025 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.

Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content

  •  
  •  
  •  
HighQ
Copyright Baker McKenzie 2025 | Disclaimers | Supplemental Privacy Statement